Home > Compound List > Compound details
138071-82-6 molecular structure
click picture or here to close

gadolinium(3+) ion 2-[4,7-bis(carboxylatomethyl)-10-(1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecan-1-yl]acetate

ChemBase ID: 4441
Molecular Formular: C18H31GdN4O9
Molecular Mass: 604.71014
Monoisotopic Mass: 605.13320659
SMILES and InChIs

SMILES:
C1CN(CCN(CCN(CCN1CC(=O)[O-])CC(=O)[O-])C(CO)C(CO)O)CC(=O)[O-].[Gd+3]
Canonical SMILES:
OCC(C(N1CCN(CCN(CCN(CC1)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])CO)O.[Gd+3]
InChI:
InChI=1S/C18H34N4O9.Gd/c23-12-14(15(25)13-24)22-7-5-20(10-17(28)29)3-1-19(9-16(26)27)2-4-21(6-8-22)11-18(30)31;/h14-15,23-25H,1-13H2,(H,26,27)(H,28,29)(H,30,31);/q;+3/p-3
InChIKey:
ZPDFIIGFYAHNSK-UHFFFAOYSA-K

Cite this record

CBID:4441 http://www.chembase.cn/molecule-4441.html

Collapse All Expand All

NAMES AND DATABASE IDS

NAMES AND DATABASE IDS

Names Database IDs
IUPAC name
gadolinium(3+) ion 2-[4,7-bis(carboxylatomethyl)-10-(1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecan-1-yl]acetate
IUPAC Traditional name
gadolinium(3+) 2-[4,7-bis(carboxylatomethyl)-10-(1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecan-1-yl]acetate
Brand Name
Gadovist
Synonyms
Gadobutrol
CAS Number
138071-82-6
PubChem SID
160967873
99443257
PubChem CID
15814656

DATA SOURCES

DATA SOURCES

All Sources Commercial Sources Non-commercial Sources
Data Source Data ID Price

CALCULATED PROPERTIES

CALCULATED PROPERTIES

JChem ALOGPS 2.1
Acid pKa 1.5443879  H Acceptors 13 
H Donor LogD (pH = 5.5) -10.374291 
LogD (pH = 7.4) -12.051273  Log P -9.238706 
Molar Refractivity 141.0588 cm3 Polarizability 42.573895 Å3
Polar Surface Area 194.04 Å2 Rotatable Bonds 10 
Lipinski's Rule of Five false 
Log P -0.47  LOG S -1.31 
Solubility (Water) 3.52e+01 g/l 

PROPERTIES

PROPERTIES

Bioassay(PubChem)

DETAILS

DETAILS

DrugBank DrugBank
DrugBank - DB06703 external link
Item Information
Drug Groups approved
Description Gadobutrol is a contrast agent used in magnetic resonance imaging (MRI).
Indication For diagnostic use only. Indicated for adults and children, age 2 and over, for contrast enhancement during cranial and spinal MRI and for contrast-enhanced magnetic resonance angiography (CE-MRA). Gadobutrol is particularly suited for where the exclusion or demonstration of additional pathology may influence the choice of therapy or patient management, for detection of very small lesions and for visualization of tumors that do not readily take up contrast media. May also be suitable for perfusion studies for the diagnosis of stroke, detection of focal cerebral ischemia and tumor perfusion.
External Links
Wikipedia

REFERENCES

REFERENCES

From Suppliers Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
    No data available
  • Searching...Please wait...

PATENTS

PATENTS

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

INTERNET

INTERNET

Baidu iconBaidu google iconGoogle